Xiwang Sugar Holdings Co Limited:企業の戦略・SWOT・財務情報

◆英語タイトル:Xiwang Sugar Holdings Co Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C3900
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥22,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥45,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥68,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Xiwang Sugar Holdings Co Limited – Strategy, SWOT and Corporate Finance Report
Summary

Xiwang Sugar Holdings Co Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Xiwang Property Holdings Company Limited (Xiwang Property), formerly Xiwang Sugar Holdings Co Limited is into the property development business. The company develops property projects including commercial, residential and office zones. The company works on property projects which include Lanting Project, Meijun Project, Qinghe Project, and a new project Yintaishan Corn Cultural Project at Shandong Province. The company along with its subsidiaries operates in China. It operates as a subsidiary of Xiwang Investment Company Limited. The company’s strategy is to achieve sustainable long term profitability and asset growth which will help the company to maximize the shareholders’ interest. Xiwang Property is headquartered in Shandong Province, China.

Scope

- Detailed information on Xiwang Sugar Holdings Co Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Xiwang Sugar Holdings Co Limited in the form of a SWOT analysis
- An in-depth view of the business model of Xiwang Sugar Holdings Co Limited including a breakdown and examination of key business segments
- Intelligence on Xiwang Sugar Holdings Co Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Xiwang Sugar Holdings Co Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Xiwang Sugar Holdings Co Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Xiwang Sugar Holdings Co Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Xiwang Sugar Holdings Co Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Xiwang Sugar Holdings Co Limited: Company Overview 7
Xiwang Sugar Holdings Co Limited: Overview and Key Facts 7
Xiwang Sugar Holdings Co Limited: Overview 7
Xiwang Sugar Holdings Co Limited: Key Facts 7
Xiwang Sugar Holdings Co Limited: Key Employees 9
Xiwang Sugar Holdings Co Limited: Key Employee Biographies 10
Xiwang Sugar Holdings Co Limited: Major Products and Services 11
Xiwang Sugar Holdings Co Limited: Company History 12
Xiwang Sugar Holdings Co Limited: Management Statement 13
Xiwang Sugar Holdings Co Limited: Locations and Subsidiaries 14
Xiwang Sugar Holdings Co Limited: Key Competitors 15
Xiwang Sugar Holdings Co Limited: Company Analysis 16
Xiwang Sugar Holdings Co Limited: Business Description 16
Xiwang Sugar Holdings Co Limited: SWOT Analysis 17
Xiwang Sugar Holdings Co Limited: SWOT Overview 17
Xiwang Sugar Holdings Co Limited: Strengths 17
Xiwang Sugar Holdings Co Limited: Weaknesses 17
Xiwang Sugar Holdings Co Limited: Opportunities 18
Xiwang Sugar Holdings Co Limited: Threats 19
Xiwang Sugar Holdings Co Limited: Corporate Financial Deals Activity 20
Xiwang Sugar Holdings Co Limited: Financial Deals Overview 20
Xiwang Sugar Holdings Co Limited: Top Deals 2014 – 2018YTD* 21
Appendix 22
Contact Us 22
Methodology 22
About MarketLine 23

List of Tables
Table 1: Xiwang Sugar Holdings Co Limited: Key Facts
Table 2: Xiwang Sugar Holdings Co Limited: Key Employees
Table 3: Xiwang Sugar Holdings Co Limited: Locations and Subsidiaries
Table 4: Xiwang Sugar Holdings Co Limited: Key Competitors
Table 5: Xiwang Sugar Holdings Co Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Xiwang Sugar Holdings Co Limited: Top Deals 2014 - 2018YTD*

List of Figures
Figure 1: Xiwang Sugar Holdings Co Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)

★海外企業調査レポート[Xiwang Sugar Holdings Co Limited:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Business Connexion Group Limited:企業の戦略的SWOT分析
    Business Connexion Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Syndax Pharmaceuticals Inc (SNDX):企業の財務・戦略的SWOT分析
    Summary Syndax Pharmaceuticals Inc (Syndax) is a biopharmaceutical company that develops and commercializes therapies for multiple cancer indications. The company’s lead product candidate includes entinostat, an oral, small molecule drug candidate, which is in phase 3 clinical trial used for the tre …
  • Celgene Corp (CELG)-製薬・医療分野:企業M&A・提携分析
    Summary Celgene Corp (Celgene) is an integrated global biopharmaceutical company that carries out the research, development, manufacture and marketing of novel therapies to treat cancer and immune-inflammatory related diseases through gene and protein regulation. Its product portfolio includes Vidaz …
  • Gulfport Energy Corp (GPOR):企業の財務・戦略的SWOT分析
    Gulfport Energy Corp (GPOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Advantest Corporation (6857):企業の財務・戦略的SWOT分析
    Advantest Corporation (6857) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Avnet, Inc.:戦略・SWOT・企業財務分析
    Avnet, Inc. - Strategy, SWOT and Corporate Finance Report Summary Avnet, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • ImmusanT Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ImmusanT Inc (ImmusanT) is a clinical stage biotechnology company that discovers, develops and delivers peptide-based immune therapies for the treatment of patients with autoimmune diseases. The company develops its therapeutic vaccines using its epitope-specific immuno-therapy (ESIT) platfo …
  • Hypera SA:企業の戦略・SWOT・財務情報
    Hypera SA - Strategy, SWOT and Corporate Finance Report Summary Hypera SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Protea Biosciences Group Inc (PRGB):企業の財務・戦略的SWOT分析
    Summary Protea Biosciences Group Inc (Protea) operates as a biotechnology company that develops mass spectometry solutions. The company offers technology for identification, characterization, and quantitation of biologically-important molecules for pharmaceutical development, research, and diagnosti …
  • Archrock Partners LP:企業のM&A・事業提携・投資動向
    Archrock Partners LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Archrock Partners LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Acadia Healthcare Company Inc:企業のM&A・事業提携・投資動向
    Acadia Healthcare Company Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Acadia Healthcare Company Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • AnaMar AB:製薬・医療:M&Aディール及び事業提携情報
    Summary AnaMar AB (AnaMar), a subsidiary of Koncentra Holding AB, is a drug discovery company that discovers, develops and commercializes therapeutic strategies to treat debilitating inflammation, fibrosis and pain. The company develops drug candidates from several chemical classes on the receptors …
  • The Nature’s Bounty Co.:企業の戦略・SWOT・財務情報
    The Nature’s Bounty Co. - Strategy, SWOT and Corporate Finance Report Summary The Nature’s Bounty Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Edward Don & Company:企業の戦略・SWOT・財務情報
    Edward Don & Company - Strategy, SWOT and Corporate Finance Report Summary Edward Don & Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Securitas AB:企業の戦略・SWOT・財務情報
    Securitas AB - Strategy, SWOT and Corporate Finance Report Summary Securitas AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Koken Co Ltd:企業の戦略的SWOT分析
    Koken Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Statkraft AS-エネルギー分野:企業M&A・提携分析
    Summary Statkraft AS (Statkraft), a subsidiary of Statkraft SF, is a power utility which produces electricity and thermal energy. It generates power from hydro, wind, gas, and bio-power sources. The company develops hydroelectric power plants across various countries. Statkraft trades and originates …
  • bet-at-home.com AG (ACX):企業の財務・戦略的SWOT分析
    bet-at-home.com AG (ACX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Schroders plc:戦略・SWOT・企業財務分析
    Schroders plc - Strategy, SWOT and Corporate Finance Report Summary Schroders plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Bio-Reference Laboratories Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bio-Reference Laboratories Inc (Bio-Reference) a subsidiary of Opko Health, Inc., is a full service clinical laboratory that specializes in genetic testing. The company provides comprehensive range of tests that focus on molecular diagnostics, genetics, anatomical pathology, oncology, and wo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆